Cetera Investment Advisers’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.08M Sell
79,315
-6,593
-8% -$433K ﹤0.01% 1612
2026
Q1
$6.11M Buy
85,908
+427
+0.5% +$33.7K 0.01% 1364
2025
Q4
$7.01M Sell
85,481
-1,045
-1% -$81.4K 0.01% 1240
2025
Q3
$6.5M Buy
86,526
+6,872
+9% +$513K 0.01% 1227
2025
Q2
$5.9M Sell
79,654
-514
-0.6% -$35.8K 0.01% 1088
2025
Q1
$6.47M Buy
80,168
+624
+0.8% +$53.6K 0.01% 969
2024
Q4
$6.22M Buy
79,544
+2,244
+3% +$191K 0.01% 933
2024
Q3
$7.25M Buy
77,300
+3,587
+5% +$301K 0.02% 826
2024
Q2
$5.74M Buy
73,713
+5,239
+8% +$427K 0.01% 935
2024
Q1
$6.23M Buy
68,474
+58,252
+570% +$4.85M 0.01% 872
2023
Q4
$790K Sell
10,222
-1,457
-12% -$102K 0.01% 1238
2023
Q3
$795K Buy
11,679
+1,443
+14% +$105K 0.01% 1158
2023
Q2
$832K Buy
10,236
+37
+0.4% +$2.95K 0.01% 1142
2023
Q1
$837K Buy
+10,199
New +$728K 0.01% 1123

Other funds holding GEHC

Cetera Investment Advisers's GEHC Position: Q2 2026 in Review

Cetera Investment Advisers reduced its GE HealthCare (GEHC) stake by 7.7% in Q2 2026, selling an estimated $433K and leaving 79,315 shares worth $5.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1612.

Cetera Investment Advisers first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $7.25M in Q3 2024. 1,230 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Cetera Investment Advisers held 79,315 shares of GE HealthCare worth $5.08M as of Q2 2026.
  • Cetera Investment Advisers sold 6,593 GE HealthCare shares in Q2 2026, an estimated $433K.
  • GE HealthCare made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #1612 holding.
  • Cetera Investment Advisers first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Cetera Investment Advisers's GE HealthCare position peaked at $7.25M in Q3 2024.
  • 1,230 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.